Moderna, Merck Drugs Combined Shown Effective Against Melanoma
U.S. pharmaceutical companies Moderna and Merck say a clinical trial for an experimental Moderna mRNA vaccine used in combination with the Merck cancer therapy drug Keytruda reduced the chance of recurrence or death from melanoma by nearly 50%. In a release from Moderna on Thursday, the company said the trial included 157 patients with high-risk … Read more
